Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|June 18, 2015
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compoundsYu Zhang, Bin Liu, Xingyu Wu, et al.American Journal of Physiology. Renal Physiology|October 10, 2014
Thienoquinolins exert diuresis by strongly inhibiting UT-A urea transportersHuiwen Ren, Yanhua Wang, Yongning Xing, et al.Biomedicines|April 29, 2025
Druggability Studies of Benzene Sulfonamide Substituted Diarylamide (E3) as a Novel DiureticHang Zhang, Shuyuan Wang, Nannan Li, et al.Journal of Neuroengineering and Rehabilitation|February 8, 2026
Prognosis prediction of patients with disorders of consciousness based on digital twin brain modelsShaoting Yan, Qing Li, Ruiqi Li, et al.European Journal of Medicinal Chemistry|November 25, 2017
Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activatorsRidong Li, Xianling Ning, Shuo Zhou, et al.European Journal of Medicinal Chemistry|October 3, 2021
N-(4-acetamidophenyl)-5-acetylfuran-2-carboxamide as a novel orally available diuretic that targets urea transporters with improved PD and PK propertiesShuyuan Wang, Yue Xu, Yan Zhao, et al.Frontiers in Pharmacology|September 9, 2017
Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer CellsWei Huang, Xia Yuan, Ting Sun, et al.Frontiers in Pharmacology|August 20, 2024
Corrigendum: Proteasome inhibitor YSY01A abrogates constitutive STAT3 signaling via down-regulation of Gp130 and JAK2 in human A549 lung cancer cellsWei Huang, Xia Yuan, Ting Sun, et al.Bioorganic Chemistry|January 18, 2024
Discovery of 2,4-diarylaminopyrimidine derivatives bearing sulfonamide moiety as novel FAK inhibitorsRidong Li, Lidong Gong, Jiawei Sun, et al.Journal of Medicinal Chemistry|February 18, 2010
Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure--activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of beta-amino acidsYongqiang Zhu, Xinrong Zhu, Gang Wu, et al.Pageof 7